Related Experiment Video
Updated: Feb 10, 2026

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
Is Transforming Stem Cells to Pancreatic Beta Cells Still the Holy Grail for Type 2 Diabetes?
Sevim Kahraman1, Erin R Okawa1,2, Rohit N Kulkarni3,4
1Section of Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Harvard Medical School, Boston, MA, 02215, USA.
Abstract:
Diabetes is a progressive disease affecting millions of people worldwide. There are several medications and treatment options to improve the life quality of people with diabetes. One of the strategies for the treatment of diabetes could be the use of human pluripotent stem cells or induced pluripotent stem cells. The recent advances in differentiation of stem cells into insulin-secreting beta-like cells in vitro make the transplantation of the stem cell-derived beta-like cells an attractive approach for treatment of type 1 and type 2 diabetes. While stem cell-derived beta-like cells provide an unlimited cell source for beta cell replacement therapies, these cells can also be used as a platform for drug screening or modeling diseases.
Insights
Human pluripotent stem cells offer a promising new avenue for diabetes treatment. These cells can be differentiated into insulin-producing beta-like cells for transplantation, potentially revolutionizing diabetes care.
Area of Science:
- Regenerative Medicine
- Endocrinology
- Cell Biology
Background:
- Diabetes mellitus is a chronic, progressive metabolic disorder affecting millions globally.
- Current treatments aim to manage blood glucose but do not offer a cure.
- Human pluripotent stem cells (hPSCs) and induced pluripotent stem cells (iPSCs) present a novel therapeutic strategy.
Purpose of the Study:
- To explore the potential of stem cell-derived beta-like cells for diabetes treatment.
- To highlight the advancements in differentiating stem cells into functional beta-like cells.
- To discuss the broader applications of these cells in drug screening and disease modeling.
Main Methods:
- Advances in in vitro differentiation protocols for hPSCs and iPSCs.
- Generation of insulin-secreting beta-like cells from pluripotent stem cells.
- Evaluation of stem cell-derived beta-like cells for transplantation potential.
Main Results:
- Successful differentiation of stem cells into functional insulin-secreting beta-like cells.
- Demonstration of stem cell-derived beta-like cells as a viable, unlimited cell source.
- Identification of potential for these cells in type 1 and type 2 diabetes therapies.
Conclusions:
- Stem cell-derived beta-like cells represent a significant advancement in regenerative medicine for diabetes.
- Transplantation of these cells offers a promising approach for beta cell replacement therapy.
- These cells also serve as a valuable platform for pharmaceutical research and diabetes modeling.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Embryonic Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Types Of Transformers
If the ratio of the number of turns in the secondary winding to that of the primary winding is greater than one, then the transformer is said to be a step-up transformer. In a step-up transformer, the voltage at the secondary winding is greater than the voltage applied at the primary winding.
However, if this ratio is less than one, the transformer is said to be a step-down...
Adult Stem Cells
Induced Pluripotent Stem Cells

